CTL019 (Novartis)

CTL019
(Novartis)

Cancer r/r DLBCL Oncology
Phase II

CTL019

This is a partner's product, where Oxford Biomedica provide process development and bioprocessing. For more information on Novartis products visit the Novartis website.